s-nitrosoglutathione has been researched along with 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tai, HH; Yamamoto, S; Yan, F; Zhou, H | 1 |
1 other study(ies) available for s-nitrosoglutathione and 7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
| Article | Year |
|---|---|
Serine 331 is the major site of receptor phosphorylation induced by agents that activate protein kinase G in HEK 293 cells overexpressing thromboxane receptor alpha.
Topics: Base Sequence; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA Primers; Enzyme Activation; Fatty Acids, Unsaturated; Glutathione; Humans; In Vitro Techniques; Mutagenesis, Site-Directed; Nitroprusside; Nitroso Compounds; Phosphorylation; Receptors, Thromboxane; Recombinant Fusion Proteins; S-Nitrosoglutathione; Serine | 2001 |